MTOR and acute myeloid leukemia: In support of MSC being the AML cell of origin, it has been previously shown that mTOR activation promotes adipogenic differentiation of human MSCs (Yu et al, 2008), while inhibition of this pathway promotes osteogenesis (Martin et al, 2010).